- Home
- LGND vs TRIP Comparison
LGND vs TRIP Comparison
Compare LGND & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGND | TRIP |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 1.1B |
| IPO Year | 1997 | 2011 |
Fundamental Metrics
Financial Performance| Metric | LGND | TRIP |
|---|---|---|
| Price | $313.82 | $8.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | ★ $256.29 | $14.40 |
| AVG Volume (30 Days) | 172.3K | ★ 4.2M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2886.36 | 675.00 |
| EPS | ★ 1.63 | N/A |
| Revenue | $141,102,000.00 | ★ $1,556,000,000.00 |
| Revenue This Year | $1.25 | $3.33 |
| Revenue Next Year | $19.41 | $5.12 |
| P/E Ratio | $192.70 | ★ N/A |
| Revenue Growth | ★ 29.48 | N/A |
| 52 Week Low | $175.89 | $8.02 |
| 52 Week High | $326.63 | $17.82 |
Technical Indicators
Market Signals| Indicator | LGND | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 70.68 | 32.00 |
| Support Level | $286.99 | N/A |
| Resistance Level | $317.49 | $15.13 |
| Average True Range (ATR) | 8.57 | 0.36 |
| MACD | 3.51 | 0.05 |
| Stochastic Oscillator | 97.03 | 22.30 |
Price Performance
Historical ComparisonAbout LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025. The company is selling TheFork, its dining brand, which represented 12% of sales.